Colony Group’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
Colony Group's RGEN Position: Q4 2021 in Review
Colony Group sold out of Repligen (RGEN) in Q4 2021, closing a stake of 1,106 shares — an estimated $320K sold.
Colony Group first reported a position in RGEN in Q2 2013 and held it in 13 quarters. The position peaked at $1.92M in Q2 2014. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.
- Colony Group reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
- Colony Group sold 1,106 Repligen shares in Q4 2021, an estimated $320K.
- Colony Group first reported a position in Repligen in Q2 2013 and held it in 13 quarters.
- Colony Group's Repligen position peaked at $1.92M in Q2 2014.
- 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.
Based on Colony Group's 13F filing for Q4 2021, filed 15 Feb 2022.